Page last updated: 2024-08-17

aminacrine and Carcinoma, Non-Small Cell Lung

aminacrine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrera, G; Cucci, MA; Czarnecka, K; Daga, M; Girek, M; Grobelski, B; Kłosiński, K; Pasieka, Z; Pizzimenti, S; Szymański, P	1
Ferguson, DM; Jacobson, BA; Jay-Dixon, J; Kratzke, RA; Patel, MR; Raza, A	1

Other Studies

2 other study(ies) available for aminacrine and Carcinoma, Non-Small Cell Lung

Article	Year
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells. Molecular and cellular biochemistry, 2019, Volume: 460, Issue:1-2 Topics: A549 Cells; Aminacrine; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cisplatin; Colorectal Neoplasms; Cytoprotection; DNA; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Histones; HT29 Cells; Humans; Hyaluronoglucosaminidase; Inhibitory Concentration 50; Iodobenzoates; Lung Neoplasms; Mutagens; Oxidative Stress; Poly(ADP-ribose) Polymerases; Tumor Stem Cell Assay	2019
Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine Derivatives. Anticancer research, 2015, Volume: 35, Issue:10 Topics: Aminacrine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Topoisomerases, Type II; Drug Synergism; Humans; Lung Neoplasms; Molecular Targeted Therapy; Topoisomerase II Inhibitors	2015

Article

Year

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.

Molecular and cellular biochemistry, 2019, Volume: 460, Issue:1-2

Topics: A549 Cells; Aminacrine; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cisplatin; Colorectal Neoplasms; Cytoprotection; DNA; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Histones; HT29 Cells; Humans; Hyaluronoglucosaminidase; Inhibitory Concentration 50; Iodobenzoates; Lung Neoplasms; Mutagens; Oxidative Stress; Poly(ADP-ribose) Polymerases; Tumor Stem Cell Assay

2019

Targeting Topoisomerase II Activity in NSCLC with 9-Aminoacridine Derivatives.

Anticancer research, 2015, Volume: 35, Issue:10

Topics: Aminacrine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Topoisomerases, Type II; Drug Synergism; Humans; Lung Neoplasms; Molecular Targeted Therapy; Topoisomerase II Inhibitors

2015